Deliciously Ella Names Baby Daughter After Her Late Mum-In-Law Tessa Jowell

Welcome to the world, Skye Tessa Camilla Davan Mills.

Ella Mills, also known as Deliciously Ella, has revealed that she’s named her newborn daughter after the baby’s late grandmother Dame Tessa Jowell.

The food blogger took to Instagram to share the news that she’d given birth to a baby girl, who she and husband Matthew Mills decided to call Skye Tessa Camilla Davan Mills.

Sharing a photo of her new family of three, Ella explained that Skye was born in a birthing pool at home on Saturday and described it as “the most powerful, surreal, totally extraordinary moment”. She took the opportunity to thank Matthew, the midwife and their doula for supporting her through the birth.

“We’re completely in love,” she added.

The baby’s father Matthew Mills is the son of the late Labour MP Tessa Jowell, who lived with a brain tumour and passed away in May 2018 at the age of 70, following a brain haemorrhage. Just months earlier, she’d bravely stood in the House of Lords calling for more funding and support for people with brain tumours, earning her a minute-long standing ovation.

At the time, Jowell said: “In the end, what gives a life meaning is not only how it is lived, but how it draws to a close.

“I hope that this debate will give hope to other cancer patients, like me, so we can live well together with cancer, not just dying of it. All of us, for longer.”

Jowell, a former Labour cabinet minister, was also instrumental in securing the 2012 London Olympics, little knowing her granddaughter would arrive on 27 June, seven years to the day after the games’ Opening Ceremony.

On Twitter over the weekend, TeamGB shared a video of highlights from the night, which has been widely retweeted and liked more than 28,000 times.

Just days after Jowell’s death, former prime minister Theresa May agreed a £20m brain tumour treatment fund as part of Jowell’s “lasting legacy”.

In May this year, health secretary Matt Hancock, announced the roll-out of a fluorescent “dye” that helps doctors target brain tumours across the NHS, “transforming care for 2,000 patients every year”.